Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
Forbes JF, Sestak I, Howell A, Bonanni B, Bundred N, Levy C, von Minckwitz G, Eiermann W, Neven P, Stierer M, Holcombe C, Coleman RE, Jones L, Ellis I, Cuzick J; IBIS-II investigators. Forbes JF, et al. Lancet. 2016 Feb 27;387(10021):866-73. doi: 10.1016/S0140-6736(15)01129-0. Epub 2015 Dec 11. Lancet. 2016. PMID: 26686313 Free PMC article. Clinical Trial.
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A; IBIS-II investigators. Cuzick J, et al. Lancet. 2014 Mar 22;383(9922):1041-8. doi: 10.1016/S0140-6736(13)62292-8. Epub 2013 Dec 12. Lancet. 2014. PMID: 24333009 Free article. Clinical Trial.
The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation.
Brindley DA, French A, Suh J, Roberts M, Davies B, Pinedo-Villanueva R, Wartolowska K, Rooke K, Kramm A, Judge A, Morrey M, Chandra A, Hurley H, Grover L, Bingham I, Siegel B, Rattley MS, Buckler RL, McKeon D, Krumholz K, Hook L, May M, Rikabi S, Pigott R, Morys M, Sabokbar A, Titus E, Laabi Y, Lemaitre G, Zahkia R, Sipp D, Horne R, Bravery C, Williams D, Wall I, Snyder EY, Karp JM, Barker RW, Bure K, Carr AJ, Reeve B. Brindley DA, et al. Among authors: rooke k. Stem Cells Dev. 2013 Dec;22 Suppl 1(Suppl 1):63-72. doi: 10.1089/scd.2013.0403. Stem Cells Dev. 2013. PMID: 24304079 Free PMC article.
Changing trends.
Rooke K. Rooke K. Mol Med Today. 2000 Oct;6(10):375. doi: 10.1016/s1357-4310(00)01793-7. Mol Med Today. 2000. PMID: 11006517 No abstract available.
Rapid update.
Perks B, Rooke K. Perks B, et al. Among authors: rooke k. Mol Med Today. 2000 Sep;6(9):337. doi: 10.1016/s1357-4310(00)01783-4. Mol Med Today. 2000. PMID: 10954867 No abstract available.
Rapid update.
Perks B, Rooke K. Perks B, et al. Among authors: rooke k. Mol Med Today. 2000 Jul;6(7):260. doi: 10.1016/s1357-4310(00)01746-9. Mol Med Today. 2000. PMID: 10859561 No abstract available.
18 results